Conmed (CNMD) Tops Q2 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $34.77 +1.05%
EPS Growth %: -5.2%
Financial Fact:
Net Income Diluted: 0.26
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -5.2%
Financial Fact:
Net Income Diluted: 0.26
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q2 EPS of $1.15, $0.03 better than the analyst estimate of $1.12. Revenue for the quarter came in at $342.34 million versus the consensus estimate of $338.4 million.
GUIDANCE:
Conmed sees FY2025 revenue of $1.36-1.39 billion, versus the consensus of $1.36 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- RH (RH) Tops Q1 EPS by 12c
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
